Transaction Expected to be Immediately Accretive to Revenue and Non-GAAP Earnings in 2022 with Multiple Drivers to Accelerate Financial Growth Through 2027 and Beyond
Read more at prnewswire.com
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
Provided By PR Newswire – Last update: